Cognizant (CTSH) Q2 2025 earnings review
Mega-Deal Wins Mask Slowing Organic Growth and Weak Cash Flow
Cognizant reported a solid Q2, beating revenue and EPS estimates while raising its full-year outlook. The headline was a massive 18% YoY increase in bookings, powered by two mega-deals each valued over $1 billion, resulting in a strong 1.4x trailing 12-month book-to-bill ratio. However, this impressive sales performance is overshadowed by a clear deceleration in the core business. Organic constant currency growth slowed to 3.2% from 4.2% last quarter, and Q3 guidance implies a further step down to ~2.3%. Additionally, weak first-half operating cash flow, which significantly lags net income, points to deteriorating working capital.
🐂 Bull Case
Bookings grew 18% YoY, driven by two mega-deals over $1 billion each. The resulting 1.4x trailing 12-month book-to-bill provides strong revenue visibility and suggests market share gains.
The largest segment, Financial Services, delivered 6.0% CC YoY growth, confirming its recovery is durable. Management noted a healthy return of discretionary spending in this key vertical.
The company increased its planned 2025 capital return to shareholders by $300 million to $2.0 billion, funded by an expected $200 million cash tax benefit from recent US legislation.
🐻 Bear Case
Headline growth is being flattered by the Belcan acquisition. The underlying organic business is slowing, and the midpoint of Q3 guidance implies the weakest organic growth rate in a year.
Operating cash flow for the first half was only $798 million, lagging net income of $1.3 billion. This, combined with a 3-day YoY increase in DSOs, signals potential collection issues or less favorable contract terms.
The Products & Resources segment saw an organic revenue decline of ~1.3% YoY CC, as trade policy uncertainty continues to pressure discretionary spending in the manufacturing and retail sectors.
⚖️ Verdict: ⚪
Mixed. The ability to win mega-deals is a clear sign that Cognizant's AI-led productivity pitch is resonating with clients seeking cost savings. However, the decelerating organic growth and weak cash flow cannot be ignored. The company is successfully winning large, strategic battles, but the broader market environment remains challenging, leading to a slowdown across the rest of the business.
Key Themes
Mega-Deal Momentum Accelerates
Cognizant's large-deal engine is firing on all cylinders. The company booked six deals over $100M TCV in Q2, including two mega-deals of approximately $1B each. This drove bookings up 18% YoY, a sharp reversal from the 7% decline in Q1. CEO Ravi Kumar noted that while many large deals are driven by AI-led productivity savings, the company is starting to see more innovation-led projects, suggesting new client spending cycles are opening up.
Financial Services Recovery is Sustained
The turnaround in the Financial Services segment, the company's largest, appears complete and durable. The segment grew 6.0% YoY CC, building on Q1's 6.5% growth. This marks a significant recovery from declines seen a year ago and is driven by broad-based demand for digital engineering, legacy modernization, and vendor consolidation projects, particularly in North America.
Organic Growth is Decelerating
While reported revenue growth of 7.2% CC was strong, it was propped up by a 400 basis point contribution from the Belcan acquisition. Organic growth was 3.2% CC, a full percentage point lower than the 4.2% achieved in Q1. Critically, Q3 guidance for total CC growth of 3.5%-5.0% (midpoint 4.25%) with a ~200 bps inorganic contribution implies organic growth will slow further to just ~2.25%. This contradicts the narrative of accelerating momentum.
AI Strategy Moves from Concept to Product
Cognizant is formalizing its AI strategy with new offerings. The launch of 'Cognizant Agent Foundry' aims to help clients deploy autonomous AI agents at scale, moving beyond experimentation. This is coupled with a new 'AI Training Data Services' offering, leveraging an internal team of 10,000 specialists to help enterprises build and fine-tune their own AI models. These initiatives represent a strategic push to create monetizable, IP-led solutions.
Working Capital Weakness
A key red flag this quarter is poor cash conversion. Year-to-date operating cash flow of $798M represents only 61% of net income ($1,308M). This is corroborated by a rise in Days Sales Outstanding (DSO) to 83 days, up from 80 a year ago. This trend suggests potential issues with accounts receivable collections or less favorable payment terms on the new slate of large deals.
Macro Environment Remains Unchanged
Management described the overall demand environment as 'largely unchanged' with 'limited visibility'. The commentary suggests that Cognizant's growth is primarily coming from market share gains through competitive vendor consolidation deals, rather than from a broad-based recovery in enterprise IT spending. The low end of the full-year guidance continues to assume a potential deterioration in demand.
Other KPIs
This strong metric, up from 1.3x in Q1, is the primary bull case for the stock. It indicates that contract wins are significantly outpacing revenue recognition, providing a healthy backlog that supports future growth and offers a buffer against continued macro uncertainty.
Trailing Net Income significantly. While the company raised its full-year Free Cash Flow outlook, this was due to a one-time cash tax benefit from new legislation. The underlying operational cash generation in the first half has been weak, and a return to converting over 100% of net income to free cash flow from operations will be critical to watch.
Guidance
Decelerating. The midpoint of 4.25% represents a significant slowdown from Q2's 7.2% growth. This is driven by both a tougher prior-year comparison and a slowdown in the underlying organic business. The inorganic contribution from Belcan is guided to drop from 400 bps in Q2 to just over 200 bps in Q3.
Stable / Slightly Up. The range was narrowed and the midpoint was raised slightly to 5.0% from 4.75% previously. This reflects the solid first-half performance but still implies a slower second half, consistent with the Q3 guide.
Accelerating. The midpoint of $5.15 implies 8.4% YoY growth over FY24's $4.75. This is an increase from the prior guidance range and reflects the Q2 beat, higher revenue outlook, and favorable currency movements.